Skip to main content
Livermore
Livermore
ZHEN

Latigo Biotherapeutics, Inc.

LTGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002056611

In the last 90 days, Latigo Biotherapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of LTGO

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Latigo Biotherapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of LTGO
HolderLatest formStakeChangeFirst filedLatest filingFiling
Foresite Capital Fund VI LP13D14.50%9.18M sharesNewAug 17, 20261 filingAug 17, 2026SEC
Ra Capital Management, L.P.13G8.40%5.30M sharesNewAug 17, 20261 filingAug 17, 2026SEC
Deep Track Capital, LP13G7.03%4.45M sharesNewAug 13, 20261 filingAug 13, 2026SEC
AI Biotechnology LLC13G5.00%3.19M sharesNewAug 18, 20261 filingAug 18, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Latigo Biotherapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on LTGO
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 18, 20266:17 PM ETAI Biotechnology LLCand 3 others13G5.00%3.19M sharesNewAug 11, 2026SEC
Aug 17, 20267:06 PM ETForesite Capital Fund VI LPand 6 others13D14.50%9.18M sharesNewAug 10, 2026SEC
Aug 17, 20265:09 PM ETRa Capital Management, L.P.and 3 others13G8.40%5.30M sharesNewAug 10, 2026SEC
Aug 13, 20264:05 PM ETDeep Track Capital, LPand 2 others13G7.03%4.45M sharesNewAug 7, 2026SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Latigo Biotherapeutics, Inc. shares.

No Form 144 notices for Latigo Biotherapeutics, Inc. are on file.